Keywords: SOM Biotech, Pipeline, Financing, Patents, Asthma, SOM-0525, SOM-1033
Spain’s SOM Biotech reports progress and closes first financing
Article | 15 March 2011
Barcelona, Spain-based start-up company SOM Biotech reports significant progress on its trajectory towards pipeline development and candidate out-licensing.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
